Biochem Biophys Res Commun
Biochemical and Biophysical Research Communications
0006-291X
1090-2104
Academic Press


1899526
17560943
YBBRC18954
10.1016/j.bbrc.2007.05.177
Article


An outwardly rectifying anionic background current in atrial myocytes from the human heart

Li
H.

a

Zhang
H.

c

Hancox
J.C.

jules.hancox@bristol.ac.uk
b
⁎

Kozlowski
R.Z.

roland.kozlowski@lectusth.com
a
⁎
1


a
Department of Pharmacology, Bristol Heart Institute, School of Medical Sciences, The University of Bristol, University Walk, Bristol BS8 1TD, UK

b
Department of Physiology, Bristol Heart Institute, School of Medical Sciences, The University of Bristol, University Walk, Bristol BS8 1TD, UK

c
Biological Physics Group, School of Physics & Astronomy, The University of Manchester, Manchester M60 1QD, UK

⁎
jules.hancox@bristol.ac.uk
roland.kozlowski@lectusth.com

1
Present address: Lectus Therapeutics Limited, Babraham Research Campus, Cambridge CB223AT, UK.


03
8
2007

359
3
765
770
23
5
2007


© 2007 Elsevier Inc.
2007
Elsevier Inc.
certain conditions
.


Abstract
I
ANION
I
ANION
I
ANION
I
ANION
−
I
ANION
I
ANION
 can influence the human atrial AP profile.

Keywords
Action potential
Anion
Anionic
Atrium
Atrial myocyte
Background current
Cardiac
Computer modelling
Heart
Patch-clamp



−
E
Cl
[1]
E
Cl
−
E
Cl
−
−
[1–3]
[1–3]
I
Cl,cAMP
[4–6]
−
I
Cl,Swell
[7–9]
2+
−
I
Cl,Ca
[10–12]
).
I
AB
[13,14]
I
AB
−
(
NO

3



-


>
I

−


>
Cl

-


)


−
2+
[13,14]
I
AB
[14]
I
AB
[13]
[15,16]
I
AB
I
AB
I
ANION
I
ANION
I
AB
[13,14]
[17]
.
Methods
Atrial myocyte isolation
Table 1
2
Table 1
2
2
 at 37 °C. After 15 min, the incubation medium was substituted for the same solution containing collagenase only. Myocytes were progressively released from the chunks into the supernatant and their yield monitored under a microscope. The suspension was washed in enzyme-free solution and the myocytes were stored at room temperature until use (within ∼8 h of cell isolation).

Electrophysiology
Solutions used.
I
AB
[14]
Table 1
Table 1
Table 1
N
d
N
-(2-naphthalenyl)-((3,5-dibromo-2,4-dihydroxyphenyl)methylene)glycine hydrazide (Gly H-101), which was solved in distilled water. The hyperosmotic external solution (solution F) was prepared by adding 70 mM sucrose to solution E. A Cs-based pipette solution (solution I) was used for all experiments. Solution I was sodium-free to prevent contamination of chloride currents by the sodium–calcium exchanger current.
Drugs.
N
-(2-naphthalenyl)-((3,5-dibromo-2,4-dihydroxyphenyl)methylene)glycine hydrazide (Gly H-101, final concentrations of 10 and 30 μM) was purchased from Merck (Frankfurt, Germany). All the drug-containing solutions were protected from light throughout.

Electrophysiological recording
−1
+
2+
-current.
Recordings were made using an Axopatch 200A amplifier, and data were recorded on computer using pClamp v. 9.0 software (Axon Instruments, Forster City, CA). Data were analyzed using the Clampfit program of pClamp v. 9.0.
NO

3



-




t
NO

3



-




p
 < 0.05).

Human atrial action potential simulations
[18]
I
ANION
NO

3



-




−
Figs. 1 and 2
[18]
I
ANION
(1)
I

ANION


=
g

ANION


(
V
-
E

ANION


)

1
-
c
×
e

(
d
×
(
V
-
E

ANION


)
)






E
ANION
g
ANION
I
ANION
(1)
Fig. 1
Fig. 2
g
ANION
E
ANION
c
d
−4
−1
NO

3



-




I
ANION
g
ANION
c
d
−4
−1
−
I
ANION
.


Results and discussion
I
AB
[14]
Fig. 1
Fig. 1
−
−
NO

3



-




−
−
NO

3



-




−
−
Fig. 1
−
−
NO

3



-




−
−
Fig. 1
NO

3



-




−
−
I
ANION
I
AB
I
AB
NO

3



-




NO

3



-


>
I

-


>
Cl

-




[13,14]
).
Fig. 2
I
ANION
NO

3



-




I
ANION
NO

3



-




−
E
rev
I
ANION
E
rev
I
Cl, Swell
[15,17,19–21]
I
ANION
I
Cl,Swell
−
NO

3



-




[14]
Fig. 2
I
ANION
I
V
Fig. 2
I
ANION
I
Cl,Swell
.
I
ANION
Fig. 2
NO

3



-




I
ANION
I
Cl,Swell
[19,21]
I
AB
[14]
I
ANION
I
ANION
−
−
NO

3



-




I
ANION
I
AB
[13,14]
I
ANION
I
Cl,Swell
[1]
[17]
p
I
ANION
−
I
ANION
50
[22]
50
[22]
I
Ca,cAMP
[1,15,19–21,23]
[15,19–21]
I
Cl,Ca
[24]
Table 1
2+
2+
i
I
ANION
I
AB
[13,14]
 but also from the three major reported cardiac anion conductances in: (i) being basally active and (ii) its overall pharmacological profile and sensitivity to anion substitution.
I
ANION
Fig. 3
[18]
I
ANION
Fig. 3
NO

3



-




−
I
ANION
50
50
I
ANION
3
I
ANION
90
90
I
ANION
−
I
ANION
NO

3



-




I
ANION
I
ANION
I
Ca,L
I
Ca,L
I
ANION
I
ANION
I
Ca,L
50
Fig. 3
I
ANION
I
ANION
 influences the susceptibility of human atrial cells and tissue to arrhythmia and to pursue the underlying identity and regulation of this novel background conductance.


Acknowledgments
This study was funded by British Heart Foundation project Grant PG/04/047. The authors thank Professor G. Angelini and Mr. A. Bryan for their assistance in the provision of atrial biopsy samples and Dr. A. James for advice on human atrial myocyte cell isolation.

References
[1]
Sorota
S.


Insights into the structure, distribution and function of the cardiac chloride channels
Cardiovasc. Res.
1999
42
361
376
10533573


[2]
Hume
J.R.

Duan
D.

Collier
M.L.

Yamazaki
J.

Horowitz
B.


Anion transport in heart
Physiol. Rev.
2000
80
31
81
10617765


[3]
Mulvaney
A.W.

Spencer
C.I.

Culliford
S.

Borg
J.J.

Davies
S.G.

Kozlowski
R.Z.


Cardiac chloride channels: physiology, pharmacology and approaches for identifying novel modulators of activity
Drug Discov. Today
2000
5
492
505
11084386


[4]
Harvey
R.D.

Hume
J.R.


Autonomic regulation of a chloride current in heart
Science
1989
244
983
985
2543073


[5]
Bahinski
A.

Nairn
A.C.

Greengard
P.

Gadsby
D.C.


Chloride conductance regulated by cyclic AMP-dependent protein kinase in cardiac myocytes
Nature
1989
340
718
721
2475783


[6]
Matsuoka
S.

Ehara
T.

Noma
A.


Chloride-sensitive nature of the adrenaline-induced current in guinea-pig cardiac myocytes
J. Physiol.
1990
425
579
598
1698979


[7]
Sorota
S.


Swelling-induced chloride-sensitive current in canine atrial cells revealed by whole-cell patch-clamp method
Circ. Res.
1992
70
679
687
1551194


[8]
Tseng
G.N.


Cell swelling increases membrane conductance of canine cardiac cells: evidence for a volume-sensitive Cl− channel
Am. J. Physiol.
1992
262
C1056
C1068
1314484


[9]
Vandenberg
J.I.

Yoshida
A.

Kirk
K.

Powell
T.


Swelling-activated and isoprenaline-activated chloride currents in guinea pig cardiac myocytes have distinct electrophysiology and pharmacology
J. Gen. Physiol.
1994
104
997
1017
7699368


[10]
Kawano
S.

Hirayama
Y.

Hiraoka
M.


Activation mechanism of Ca2+-sensitive transient outward current in rabbit ventricular myocytes
J. Physiol.
1995
486
593
604
7473222


[11]
Sipido
K.R.

Callewaert
G.

Carmeliet
E.


[Ca2+]i transients and [Ca2+]i-dependent chloride current in single Purkinje cells from rabbit heart
J. Physiol.
1993
468
641
667
8254529


[12]
Zygmunt
A.C.

Gibbons
W.R.


Properties of the calcium-activated chloride current in heart
J. Gen. Physiol.
1992
99
391
414
1375275


[13]
Spencer
C.I.

Uchida
W.

Kozlowski
R.Z.


A novel anionic conductance affects action potential duration in isolated rat ventricular myocytes
Br. J. Pharmacol.
2000
129
235
238
10694227


[14]
Borg
J.J.

Hancox
J.C.

Spencer
C.I.

Kozlowski
R.Z.


Tefluthrin modulates a novel anionic background conductance (IAB) in guinea-pig ventricular myocytes
Biochem. Biophys. Res. Comm.
2002
292
208
215
11890694


[15]
Li
G.R.

Feng
J.

Wang
Z.

Nattel
S.


Transmembrane chloride currents in human atrial myocytes
Am. J. Physiol.
1996
270
C500
C507
8779912


[16]
Berul
C.I.

Sweeten
T.

Vetter
V.L.

Morad
M.


Lack of cystic fibrosis transmembrane regulator-type chloride current in pediatric human atrial myocytes
Life Sci.
1997
60
189
197
9000643


[17]
Demion
M.

Guinamard
R.

El Chemaly
A.

Rahmati
M.

Bois
P.


An outwardly rectifying chloride channel in human atrial cardiomyocytes
J. Cardiovasc. Electrophysiol.
2006
17
60
68
16426403


[18]
Courtemanche
M.

Ramirez
R.J.

Nattel
S.


Ionic mechanisms underlying human atrial action potentials: insights from a mathematical model
Am. J. Physiol.
1998
275
H301
H321
9688927


[19]
Sato
R.

Koumi
S.


Characterization of the stretch-activated chloride channel in isolated human atrial myocytes
J. Membr. Biol.
1998
163
67
76
9569251


[20]
Sakai
R.

Hagiwara
N.

Kasanuki
H.

Hosoda
S.


Chloride conductance in human atrial cells
J. Mol. Cell. Cardiol.
1995
27
2403
2408
8576955


[21]
Oz
M.C.

Sorota
S.


Forskolin stimulates swelling-induced chloride current, not cardiac cystic fibrosis transmembrane-conductance regulator current, in human cardiac myocytes
Circ. Res.
1995
76
1063
1070
7538915


[22]
Muanprasat
C.

Sonawane
N.D.

Salinas
D.

Taddei
A.

Galietta
L.J.

Verkman
A.S.


Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy
J. Gen. Physiol.
2004
124
125
137
15277574


[23]
Tsai
C.S.

Cheng
T.H.

Lin
C.I.

Chen
J.J.

Lee
F.Y.

Li
C.Y.

Hong
H.J.

Loh
S.H.


Inhibitory effect of endothelin-1 on the isoproterenol-induced chloride current in human cardiac myocytes
Eur. J. Pharmacol.
2001
424
97
105
11476755


[24]
Koster
O.F.

Szigeti
G.P.

Beuckelmann
D.J.


Characterization of a [Ca2+]i-dependent current in human atrial and ventricular cardiomyocytes in the absence of Na+ and K+
Cardiovasc. Res.
1999
41
175
187
10325965




Fig. 1
I
−
NO

3



-




−
I
−
NO

3



-




−
NO

3



-




n
−
n
−
n
p
p
NO

3



-




).



Fig. 2
I
V
NO

3



-




n
I
V
NO

3



-




n
p
NO

3



-




NO

3



-




NO

3



-




n
n
n
n
n
n
p
p
NO

3



-




).



Fig. 3
I
ANION
NO

3



-




−
I
ANION
2+
I
Ca,L
NO

3



-




−
I
ANION
.



Table 1
Composition of solutions used in this study

Chemical




1

2

2

2

2

2

3

1

2



NaCl
145
−
−
−
−
−
−
137
−

KCl
4
−
−
−
−
−
−
−
−

2

1
2.5
2.5
2.5
2.5
2.5
−
−
0.5

2

2
−
−
−
−
−
−
−
−

Glucose
10
10
10
10
10
10
140
10
−

HEPES
10
5
5
5
5
5
10
5
−

NMDG-Cl
−
135
−
−
−
−
−
−
−

NMDG-Aspartate
−
−
135
−
−
−
−
−
−

NMDG-I
−
−
−
135
−
−
−
−
−

3

−
−
−
−
135
135
−
−
−

TEACl
−
5
5
5
5
5
−
−
−

2

−
2
2
2
2
2
−
−
−

2

−
0.5
0.5
0.5
0.5
0.5
−
−
−

Sucrose
−
−
−
−
−
70
−
−
−

Cs glutamate
−
−
−
−
−
−
−
−
75

CsCl
−
−
−
−
−
−
−
−
20

CsEGTA
−
−
−
−
−
−
−
−
0.05

MgATP (tris-salt)
−
−
−
−
−
−
−
−
10

Tris-phosphocreatine
−
−
−
−
−
−
−
−
5

Tris-GTP
−
−
−
−
−
−
−
−
0.1

Pyruvic acid
−
−
−
−
−
−
−
−
5

4
Pipes
−
−
−
−
−
−
−
−
30

Adenosine
−
−
−
−
−
−
5
−
−

EGTA
−
−
−
−
−
−
−
0.2
−

2
4

−
−
−
−
−
−
50
5
−

Mannitol
−
−
−
−
−
−
100
−
−

4

−
−
−
−
−
−
8
1
−

−
 concentration
155
150
15
15
15
15
0
137
21

Osmolarity (mOsm)
308 ± 2.5
305 ± 1.2
306 ± 0.3
310 ± 3
305 ± 0.2
365 ± 1.5
383 ± 0.3
282 ± 0.6
308 ± 1.2



Osmolarities for each solution are measured values (see Methods).
Note.
1
2
3
4
3
. Minus sign indicates absence.





